CatSci Ltd is delighted to announce that we have been shortlisted as a finalist for the Bionow Export of the Year Award. We are honoured to be recognised as a global innovation partner for pharmaceutical companies across the world.
As a UK-based company in the competitive and dynamic pharmaceutical CRO marketplace, we are proud to be acknowledged for our innovative internationalisation strategy. In order to continue to meet the global needs of patients, we will carry on evolving. We have significant plans to facilitate this growth, including expansion into related CMC activities, primarily analytical development, material science, and formulation development.
Since CatSci’s origins, our purpose has always been to get safe, sustainable, and cost-effective medicines into the hands of those who need them. We are incredibly proud to be working towards this vision every day, which is why we are delighted by this recognition of our efforts to support our global partners.
Geoff Davison, CEO of Bionow said: “We were blown away by the quality of the applications we received this year and are thrilled to have such a prestigious shortlist for our first in-person awards ceremony since the pandemic began.”
